期刊文献+

上海市长风社区糖尿病高危人群代谢综合征患病情况调查 被引量:2

Prevalence of metabolic syndrome in population at high-risk for diabetes in Changfeng community of Shanghai
原文传递
导出
摘要 目的了解社区糖尿病高危人群代谢综合征(MS)的患病情况。方法对上海市长风社区982名40~79岁、有糖尿病高危因素、无明确糖尿病史的社区居民,进行问卷调查及相关检查,观察MS的检出情况及其临床特征。结果MS检出率为44.6%(438/982);男性MS检出率低于女性[34.5%(97/281)与48.6%(341/701),P〈0.01],女性MS的检出率随着年龄的增加而增高(P〈0.01),但男性MS检出率和年龄的相关性无统计学意义(P〉0.05)。MS组分分布由高到低依次为高血压66.5%(653/982),腹型肥胖62.8%(617/982),低高密度脂蛋白胆固醇(HDL-C)49.4%(485/982),高甘油三酯(TG)46.0%(452/982)和空腹血糖增高35.7%(351/982)。同时有腹型肥胖以外3个及3个以上MS组分者55.9%(245/438)。结论社区糖尿病高危人群中有较高的MS检出率,MS患者中以同时有较多的心血管危险因素者居多。 Objective To investigate prevalence of metabolic syndrome (MS) in population at high-risk for diabetes in Changfeng community of Shanghai. Methods Totally, 982 persons aged 40 - 79 years without previous history of diabetes, but with risk factors for diabetes from Changfeng community in Shanghai were screened by questionnaire, physical examinations, lipid profile and oral glucose tolerance test. Prevalence of MS and its clinical characteristic were observed. Results Overall prevalence of MS was 44.6% (438/982) in Changfeng community, significantly higher in women of 48. 6% (341/701) than that in men of 34. 5% (97/281) (P 〈0. 01 ). Prevalence of MS increased with age in women (P 〈0. 01 ), but not in men (P 〉 0. 05 ). Components of MS ranking from high to low were hypertension of 66. 5% (653/982), abdominal obesity of 62. 8% (617/982), decreased high-density lipoprotein-cholesterol (HDL-C) of 49.4% (485/982), increased triglyceride (TG) of 46. 0% (452/982) and increased fasting glucose of 35.7% (351/982). There were 55.9% (245/438) of MS patients with three or more MS components in addition to abdominal obesity. Conclusions Prevalence of MS is higher in community population at high-risk for diabetes and more than haft of the MS patients have three or more risk factors for cardiovascular disease.
出处 《中华全科医师杂志》 2008年第10期674-676,共3页 Chinese Journal of General Practitioners
基金 上海市科学技术委员会重大项目资助(04dz19501-1)
关键词 代谢综合征 普查 危险因素 Metabolic syndrome Mass screening Risk factors
  • 相关文献

参考文献7

  • 1Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome :an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005, 112:2735-2752.
  • 2江孙芳,高鑫,盛建华,陈旭昇,吴琳,李湘,张斌,赵耐青.上海市长风社区2型糖尿病高危人群糖代谢异常和危险因素分析[J].中华全科医师杂志,2007,6(8):466-469. 被引量:10
  • 3American Diabetes Association. Screening for type 2 diabetes. Diabetes Care, 2004, 27 Suppl 1: S11-S14.
  • 4宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:610
  • 5Ford ES, Giles WH, Dietz WH. Prevalence of the metabohc syndrome among US adults : findings from the third National Health and Nutrition Examination Survey. JAMA, 2002, 287:356-359.
  • 6陈蕾,贾伟平,陆俊茜,包玉倩,吴元民,姜素英,项坤三.上海市成人代谢综合征流行调查[J].中华心血管病杂志,2003,31(12):909-912. 被引量:336
  • 7Son le NT, Kunii D, Hung NT, et al. The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabetes Res Clin Pract , 2005, 67: 243-250.

二级参考文献33

  • 1王先令,陆菊明,潘长玉,田慧.空腹血糖受损诊断标准下调对糖调节受损人群检出率的影响[J].中华糖尿病杂志(1006-6187),2005,13(4):265-268. 被引量:17
  • 2李锐,卢伟,贾伟平,黎衍云,施亮,刘美霞,耿国柱,傅华,施榕,史君衡,史虹莉,张胜年.上海市2型糖尿病患病情况现状调查[J].中华医学杂志,2006,86(24):1675-1680. 被引量:105
  • 3Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 4Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 5Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 6Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 7Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 8Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 9Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.
  • 10Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.

共引文献936

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部